Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 10Completed 6Recruiting 3Withdrawn 2Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Burkitt Lymphoma 2Lymphoma, T-Cell 1Lymphoma, Follicular 1

Interventions

Rituximab 9Cyclophosphamide 9ibrutinib 7fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 7Whole-Body Irradiation 4Radiotherapy 4Filgrastim 4Cytarabine 4Bendamustine Hydrochloride 4fludarabine 3Vincristine 3Prednisone 3Mycophenolic Acid 3Melphalan 3Lenalidomide 3Etoposide 3Doxorubicin 3Carmustine 3Tacrolimus 2Pentostatin 2Pentetic Acid 2Methotrexate 2Magnetic Resonance Spectroscopy 2Dexamethasone 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2CT-P10 2Bortezomib 2venetoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Lymphoma, Mantle-Cell × CT-P10 × Clear all
NCT03579927 2020-01-29

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT03232307 2019-08-22

Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡